MedPath

Strategy to Adapt Botulinum Toxin Doses in Dystonia

Not yet recruiting
Conditions
Dystonia
Registration Number
NCT06386848
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The study is designed to observ and collect the doses of botulinum toxin injected in dystonia in different centres to compare the initial dose and the dose recommended.

We we ll study the increase of the dose injected over the time, the side effects...

The hypothesis is that we inject smaller doses than we could regarding the recommandations

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • patients over 18 years old followed for dystonia and treated with botulinum toxin
Exclusion Criteria
  • first dose of botulinum toxin not available

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
First dose of botulinum toxin injected, U30 years

dose injected in U

Secondary Outcome Measures
NameTimeMethod
Effective dose of botulinum toxin30 years

dose injected in U

Side effects30 years

diplopia, ptosis and others

© Copyright 2025. All Rights Reserved by MedPath